PHIBRO ANIMAL HEALTH CORP

SEC 4 · Filed

0001104659-26-028472Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 12, 2026

Conversion by BENDHEIM JACK, BFI Co., LLC

Security
Class B Common Stock
Code
C
Shares
100,000
Price per share
0.00
Structured facts
{
  "code": "C",
  "date": "2026-03-12",
  "direction": "D",
  "exercise_price": "0",
  "expiration": null,
  "footnotes": {
    "F1": "Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder\u0027s election, and has no expiration date.",
    "F2": "The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."
  },
  "owners": [
    {
      "cik": "0001241560",
      "name": "BENDHEIM JACK",
      "roles": [
        "director",
        "officer",
        "ten_percent_owner"
      ],
      "title": "President and CEO"
    },
    {
      "cik": "0001601607",
      "name": "BFI Co., LLC",
      "roles": [
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "19596034",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Class B Common Stock",
  "shares": "100000",
  "table": "II",
  "underlying_security": "Class A Common Stock",
  "underlying_shares": "100000"
}
Insider transactionsEvent date Mar 13, 2026

Sale by BENDHEIM JACK, BFI Co., LLC

Security
Class A Common Stock
Code
S
Shares
5,280
Price per share
48.91
Structured facts
{
  "code": "S",
  "date": "2026-03-13",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.",
    "F3": "The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on December 11, 2025.",
    "F4": "The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.48 to $49.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
  },
  "owners": [
    {
      "cik": "0001241560",
      "name": "BENDHEIM JACK",
      "roles": [
        "director",
        "officer",
        "ten_percent_owner"
      ],
      "title": "President and CEO"
    },
    {
      "cik": "0001601607",
      "name": "BFI Co., LLC",
      "roles": [
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "96200",
  "price": "48.91",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Class A Common Stock",
  "shares": "5280",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 12, 2026

Conversion by BENDHEIM JACK, BFI Co., LLC

Security
Class A Common Stock
Code
C
Shares
100,000
Price per share
0.00
Structured facts
{
  "code": "C",
  "date": "2026-03-12",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder\u0027s election, and has no expiration date.",
    "F2": "The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."
  },
  "owners": [
    {
      "cik": "0001241560",
      "name": "BENDHEIM JACK",
      "roles": [
        "director",
        "officer",
        "ten_percent_owner"
      ],
      "title": "President and CEO"
    },
    {
      "cik": "0001601607",
      "name": "BFI Co., LLC",
      "roles": [
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "101480",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Class A Common Stock",
  "shares": "100000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}